Prior transurethral resection does not increase morbidity following real-time ultrasound-guided prostate seed implantation.

Techniques in urology Pub Date : 2000-06-01
N N Stone, E R Ratnow, R G Stock
{"title":"Prior transurethral resection does not increase morbidity following real-time ultrasound-guided prostate seed implantation.","authors":"N N Stone,&nbsp;E R Ratnow,&nbsp;R G Stock","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Patients with localized prostate cancer who had a prior open prostatectomy or transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH) may be at risk for greater morbidity when treated with brachytherapy. This analysis examines the morbidity following brachytherapy using the real-time method to determine if patients with a history of TURP are at increase risk for developing complications.</p><p><strong>Materials and methods: </strong>An ultrasound-guided transperineal interactive prostate seed was implanted in 419 patients with T1-T2 prostate cancer. All patients were implanted using a peripheral weighting of sources (75%) with the interior sources placed at least 5 mm from the urethra. The patients were divided into two groups: group 1 consisted of 376 patients (89.7%) without a prior TURP, and group 2 consisted of 43 patients (10.3%) who had a TURP prior to their implant. The mean age, prostate-specific antigen level, Gleason score, clinical stage, prostate volume, isotope implanted, and number of patients treated with neoadjuvant hormone therapy were comparable for both groups.</p><p><strong>Results: </strong>Median follow-up for group 1 was 12 months and for group 2 was 18 months. No patients suffered from radiation-related proctitis or cystitis in either group of patients. Two patients in group 2 implanted with iodine 125 and who had a history of two prior TURPs developed mild superficial urethral necrosis (SUN). The actuarial freedom from developing superficial urethral necrosis at 4 years was 84% in patients with a history of prior TURP. There were no episodes of SUN in group 1 and no cases of incontinence reported in either group of patients. The actuarial rate of potency was 78% at 2 years.</p><p><strong>Conclusion: </strong>Whereas other techniques of seed implantation report incontinence in patients who had a prior open prostatectomy or TURP, the real-time method combined with peripheral loading avoids this complication.</p>","PeriodicalId":79536,"journal":{"name":"Techniques in urology","volume":"6 2","pages":"123-7"},"PeriodicalIF":0.0000,"publicationDate":"2000-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Techniques in urology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Patients with localized prostate cancer who had a prior open prostatectomy or transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH) may be at risk for greater morbidity when treated with brachytherapy. This analysis examines the morbidity following brachytherapy using the real-time method to determine if patients with a history of TURP are at increase risk for developing complications.

Materials and methods: An ultrasound-guided transperineal interactive prostate seed was implanted in 419 patients with T1-T2 prostate cancer. All patients were implanted using a peripheral weighting of sources (75%) with the interior sources placed at least 5 mm from the urethra. The patients were divided into two groups: group 1 consisted of 376 patients (89.7%) without a prior TURP, and group 2 consisted of 43 patients (10.3%) who had a TURP prior to their implant. The mean age, prostate-specific antigen level, Gleason score, clinical stage, prostate volume, isotope implanted, and number of patients treated with neoadjuvant hormone therapy were comparable for both groups.

Results: Median follow-up for group 1 was 12 months and for group 2 was 18 months. No patients suffered from radiation-related proctitis or cystitis in either group of patients. Two patients in group 2 implanted with iodine 125 and who had a history of two prior TURPs developed mild superficial urethral necrosis (SUN). The actuarial freedom from developing superficial urethral necrosis at 4 years was 84% in patients with a history of prior TURP. There were no episodes of SUN in group 1 and no cases of incontinence reported in either group of patients. The actuarial rate of potency was 78% at 2 years.

Conclusion: Whereas other techniques of seed implantation report incontinence in patients who had a prior open prostatectomy or TURP, the real-time method combined with peripheral loading avoids this complication.

事先经尿道切除术不会增加实时超声引导前列腺粒子植入后的发病率。
目的:因良性前列腺增生(BPH)而行开放性前列腺切除术或经尿道前列腺切除术(TURP)的局限性前列腺癌患者在接受近距离放疗时可能有更高的发病率风险。本分析采用实时方法检查近距离放疗后的发病率,以确定有TURP病史的患者发生并发症的风险是否增加。材料与方法:对419例T1-T2前列腺癌患者行超声引导下经会阴交互式前列腺种子植入术。所有患者均采用外周加重源(75%)植入,内源放置在距尿道至少5mm的位置。患者被分为两组:第一组376例(89.7%)患者未做过TURP手术,第二组43例(10.3%)患者在种植前做过TURP手术。两组患者的平均年龄、前列腺特异性抗原水平、Gleason评分、临床分期、前列腺体积、同位素植入和接受新辅助激素治疗的患者数量具有可比性。结果:组1中位随访时间为12个月,组2中位随访时间为18个月。两组患者均无放射相关性直肠炎或膀胱炎。2组有2例既往有2次turp病史的碘125植入患者出现轻度浅表性尿道坏死(SUN)。在有TURP病史的患者中,4年未发生尿道浅表性坏死的精算自由度为84%。在第一组中没有太阳发作,两组患者均未报告尿失禁病例。2年时效力精算率为78%。结论:尽管其他种子植入技术报告了先前进行过开放性前列腺切除术或TURP的患者出现尿失禁,但实时方法结合外周负荷避免了这种并发症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信